Sign In
Buy CNMD
$35.16
+0.0300 (+0.0854%)
At Close: Jun 05, 2026
CONMED Corporation Announces Quarterly Cash Dividend
07:00am, Tuesday, 25'th Feb 2025
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on February 24, 2025, payable on April 4
New Strong Sell Stocks for February 19th
06:15am, Wednesday, 19'th Feb 2025
ACDVF, BN and CNMD have been added to the Zacks Rank #5 (Strong Sell) List on February 19, 2024.
New Strong Sell Stocks for February 11th
06:15am, Tuesday, 11'th Feb 2025
ATS, CNMD and CSX have been added to the Zacks Rank #5 (Strong Sell) List on February 11, 2025.
CNMD's Q4 Earnings & Sales Beat Estimates, Stock Down on Weak Outlook
10:46am, Thursday, 06'th Feb 2025
CONMED reports solid fourth-quarter results, fueled by strength in the General Surgery segment and continued demand for AirSeal product.
Here's What Key Metrics Tell Us About Conmed (CNMD) Q4 Earnings
07:36pm, Wednesday, 05'th Feb 2025
Although the revenue and EPS for Conmed (CNMD) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Stree
CONMED Corporation (CNMD) Q4 2024 Earnings Call Transcript
07:05pm, Wednesday, 05'th Feb 2025
CONMED Corporation (NYSE:CNMD ) Q4 2024 Results Conference Call February 5, 2025 4:30 PM ET Company Participants Pat Beyer - Chief Executive Officer & President Todd Garner - Executive Vice President
Conmed (CNMD) Surpasses Q4 Earnings and Revenue Estimates
06:25pm, Wednesday, 05'th Feb 2025
Conmed (CNMD) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.20 per share. This compares to earnings of $1.06 per share a year ago.
CONMED Corporation Announces Fourth Quarter and Full-Year 2024 Financial Results
04:05pm, Wednesday, 05'th Feb 2025
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2024. Fourth Quarter 2024 Highlights Sales of $3
Conmed (CNMD) Earnings Expected to Grow: Should You Buy?
11:06am, Wednesday, 29'th Jan 2025
Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy CONMED (CNMD) Stock?
10:46am, Wednesday, 08'th Jan 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025
04:16pm, Monday, 06'th Jan 2025
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2024 after the market close on Wednesday, February 5, 2025. T
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
04:05pm, Thursday, 02'nd Jan 2025
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Finan
CNMD vs. ALGN: Which Stock Is the Better Value Option?
12:46pm, Thursday, 02'nd Jan 2025
Investors interested in Medical - Dental Supplies stocks are likely familiar with Conmed (CNMD) and Align Technology (ALGN). But which of these two stocks presents investors with the better value oppo
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
08:15am, Monday, 30'th Dec 2024
CNMD is poised for growth on the back of strong product offerings and recurring revenues but faces headwinds from regulatory challenges, supply-chain constraints and cybersecurity risks.
Here's Why Conmed (CNMD) is a Strong Growth Stock
10:46am, Wednesday, 11'th Dec 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
